So I came up with an interesting idea and wanted to find out some answers to a hypothetical question. Say Pharma, a major drug company, comes out with a drug to treat or alleviate the symptoms of a fictional disease that numerous people have. Their competitor, Medica, comes out with their own drug to treat or alleviate the symptoms of this same fictional disease, however the method of action is different. Numerous studies are done, and it turns out that Medica's version of the drug is superior, in addition to having fewer side effects. Pharma reacts to this news by, instead of the usual marketing pitches and sending out drug reps to hype up the drug, investing in research to come up with a compound to block Medica's drug's method of action. The research is a success, and Pharma includes this compound, which has no noticeable side effects other than rendering Medica's drug inert, in
all the drugs it produces. The result of this inclusion is that patients either have to use Pharma's less effective drug if they need to take other Pharma drugs, or stop taking Pharma's other drugs in order to start taking Medica's superior drug.
Should Pharma's inclusion of this compound in their drugs be regulated?
If Pharma's inclusion of this compound is not regulated, Pharma will invest in research to see if they can make the effects of their compound permanent, ie. if you take Pharma drugs you will never again be able to use the new Medica drug, regardless of if you stop taking the Pharma drugs. Should this be regulated?